ArticleFrontiers in oncology2026

Pilot study of topical imiquimod combined with pembrolizumab for unresectable cutaneous metastatic melanoma.

Joseph B Parker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.